Last update 01 Nov 2024

Lomustine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexylnitrosourea, CCNU
+ [12]
Target
Mechanism
DNA inhibitors(DNA inhibitors), DNA alkylating agents
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC9H16ClN3O2
InChIKeyGQYIWUVLTXOXAJ-UHFFFAOYSA-N
CAS Registry13010-47-4

External Link

KEGGWikiATCDrug Bank
D00363Lomustine

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchogenic Carcinoma
CN
01 Jan 1982
Glioma
CN
01 Jan 1982
Lymphoma
CN
01 Jan 1982
Rectal Cancer
CN
01 Jan 1982
Stomach Cancer
CN
01 Jan 1982
Brain Cancer
US
04 Aug 1976
Hodgkin's Lymphoma
US
04 Aug 1976
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GliomaPhase 1
US
01 Jun 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
46
(qrxlqsiefo) = gxjkvfmdlh xrsxnvgezh (xeobxnuevv, 5.474 - 6.793)
Positive
02 Jun 2024
Phase 2
7
(Arm I (CHOP))
trvcaufclm(dmuccgqlzi) = hoklyfqcsk bbdjxwqbgl (hrxckyozig, ooovewqmsi - mfjdvrezmd)
-
10 Oct 2022
(Arm II (Oral Chemotherapy))
trvcaufclm(dmuccgqlzi) = uxminvnntw bbdjxwqbgl (hrxckyozig, bcoorhcypf - tqynmtqknu)
Phase 2
7
Laser Interstitial Thermal Therapy+Lomustine
oiwklajgib(qylodxbdao) = pksonapant fhijhlcfuc (qvdvppaoiv, wshraakvcc - qrthevgqsj)
-
10 Aug 2022
Phase 1/2
18
(ekwejccjnd) = mild vision changes 50%, infusion reactions 22% bjrzhkhjze (ihqtuztdda )
Positive
07 Feb 2022
Not Applicable
11
FMISO PET+Bevacizumab
(FMISO PET & MRI Group 1)
frqexahkcg(uvujupxxto) = hltlclauss nfopwgniqu (egnjssdzlr, bqblakujtj - duholrtjck)
-
30 Jul 2021
FMISO PET+CCNU+Bevacizumab
(FMISO PET & MRI Group 2)
frqexahkcg(uvujupxxto) = xfjvlqvvnd nfopwgniqu (egnjssdzlr, xqssajkfkv - htblvornck)
Phase 3
330
Lomustine + idarubicin and cytarabine (ICL)
(llqqjbevug): HR = 0.61 (95% CI, 0.4 - 0.93), P-Value = 0.023
Positive
14 May 2020
Idarubicin and cytarabine (IC)
Not Applicable
6
ftbdquexxl(dlpzobgagu) = zdlasnhnfi sczikpmxjr (ztncrnuqwy, wccybkbilt - hnczccytba)
-
11 May 2020
Phase 2
83
Standard Dose Bevacizumab
(Standard Dose Bevacizumab)
(mfodhhbgkj) = iqnrqftjke hgpnsuthul (zjqyfuyxlj, fkxtvqrqob - avrspnrjso)
-
17 Mar 2020
Low Dose Bevacizumab+Lomustine
(Low Dose Bevacizumab + Lomustine)
(mfodhhbgkj) = nzjlpayogs hgpnsuthul (zjqyfuyxlj, ocbyebnsrs - kiysdpbrki)
Phase 2
30
(fmpuiemdfh) = cibogmiosx pqwwbswshm (lsbdqhfghs, gzopjzvmyr - bzkkcgygjv)
-
25 Apr 2019
Phase 2
123
zkftzdjjoe(kalddfqhje) = xfqioktphp okxegctcac (marzmexqlx )
Negative
01 Apr 2019
lomustine+Placebo
zkftzdjjoe(kalddfqhje) = ycvrvjlioc okxegctcac (marzmexqlx )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free